| 发明名称 | Use of a Chinese medicine composition in preparing medicaments for treating secondary prevention of myocardial infarction | ||
| 摘要 | The present invention relates to a use of Chinese medicine composition in preparation of medicine for secondary prevention of myocardial infarction. Said Chinese medicine composition is prepared from a formula comprising the crude drugs by the following weight percentages: Radix Astragali 22.2%˜66.8%, Radix Salviae Miltiorrhizae 11.6%˜33.4%, Radix Notoginseng 2.5%˜13.5%, and Lignum Dalbergiae Odoriferae 14.5%˜44.3%. | ||
| 申请公布号 | US9211310(B2) | 申请公布日期 | 2015.12.15 |
| 申请号 | US201113807500 | 申请日期 | 2011.06.28 |
| 申请人 | TASLY PHARMACEUTICAL GROUP CO., LTD | 发明人 | Zhang Boli;Shang Hongcai;Yao Chen;Liu Baoyan;Weng Weiliang;Zhao Yuxia;Dai Guohua;Gao Xiumei;Ren Ming;Zhang Junhua;Cao Hongbo;Mao Jingyuan;Hu Xuejun;Jin Zhisheng;Zhang Junping;Cheng Yiyu;Yan Xijun;Qu Jiazhen;Wang Hui;Xu Hongjuan;Zheng Wenke |
| 分类号 | A61K36/00;A61K36/537;A61K36/482;A61K36/258;A61K36/48;A61K36/481 | 主分类号 | A61K36/00 |
| 代理机构 | Nixon Peabody LLP | 代理人 | Nixon Peabody LLP |
| 主权项 | 1. A method for secondary prevention of myocardial infarction, said method comprising administrating to a subject in need thereof a Chinese medicine composition prepared from a formulation comprising the crude drugs by the following weight percentage:Radix Astragali22.2%-66.8%,Radix Salviae Miltiorrhizae11.6%-33.4%,Radix Notoginseng 2.5%-13.5%, andLignum Dalbergiae Odoriferae14.5%-44.3%. | ||
| 地址 | Tianjin CN | ||